How do comorbidities affect the decision to prescribe ruxolitinib for vitiligo?

Featuring Seemal Desai, MD | Education Advisor | Clinical Assistant Professor Department of DermatologyUniversity of Texas Southwestern Medical CenterDallas, TX | Published April 02, 2025